BioSpace News Archive

Targovax is Invited to Present at Upcoming 2018 Investor and Industry Conferences

Targovax ASA announces that members of its senior management will present at the following life sciences and investor conferences

November 28, 2018
·
1 min read
VALBIOTIS Recognized for its IPO at the 2018 INVESTOR AWARDS

Investors welcome VALBIOTIS’ initial public offering in 2017

November 28, 2018
·
4 min read
Policy

Vor Biopharma Announces Issuance of Foundational U.S. Patent Broadly Covering Compositions and Methods to Treat Hematologic Malignancies

The patent covers first-in-class novel hematopoietic stem cell technology for targeted immunotherapies in hematologic malignancies

November 28, 2018
·
4 min read
Dr. Reddy’s Laboratories Announces the Launch of Chlorthalidone Tablets, USP in the U.S. Market

Dr. Reddy’s Laboratories Ltd. today announced the launch of Chlorthalidone Tablets USP, 25 mg and 50 mg, a therapeutic equivalent generic version of Hygroton (chlorthalidone) Tablets, approved by the U.S. Food and Drug Administration (USFDA).

November 28, 2018
·
2 min read
BioMidwest

Online Gaming Addiction in Men Affects Brain’s Impulse Control

Researchers using functional MRI (fMRI) have found differences in the brains of men and women who are addicted to online gaming, according to a new study presented today at the annual meeting of the Radiological Society of North America (RSNA).

November 28, 2018
·
4 min read
BioMidwest

The largest behavior change study on physical activity - based on verified data - shows Vitality incentives combined with Apple Watch lead to significant and sustained increases in activity levels

The Discovery/Vitality study by RAND Europe demonstrates how incentives in the Vitality Shared-Value Insurance model combined with Apple Watch deliver dramatic and sustained improvements in physical activity levels.

November 28, 2018
·
4 min read
Business

Health Care Originals Announces Strategic Alliance With Healthport For Australia And New Zealand

Health Care Originals (HCO) announces its strategic alliance with Healthport. HCO is a leading manufacturer of medical wearables that complement digital heath technology.

November 28, 2018
·
2 min read
Drug Development

Cyxone Concludes T20K’s Preclinical Program Following Positive Results in Toxicology Studies

Cyxone (publ) announced today that the preclinical program for drug candidate T20K in multiple sclerosis (MS) has been concluded following positive results in the toxicology studies.

November 28, 2018
·
2 min read
BioMidwest

New Study Supports Mammography Screening at 30 for Some Women

A new, large-scale study of more than 5 million mammograms found that annual mammography screening beginning at age 30 may benefit women with at least one of three specific risk factors: dense breasts, a personal history of breast cancer or a family history of breast cancer.

November 28, 2018
·
4 min read
Pharm Country

Qosina Announces E-commerce Website Update

Qosina is pleased to announce the launch of its newly redesigned e-commerce website.

November 28, 2018
·
1 min read